Development of a clinical-grade extracorporeal liver support system using human induced pluripotent stem cell-derived hepatic cells

  • Post author:
  • Post category:

Liver failure is the fourth leading cause of adult death in California. Because liver cells can regenerate, some patients with liver failure could be saved without having to undergo organ…

Continue ReadingDevelopment of a clinical-grade extracorporeal liver support system using human induced pluripotent stem cell-derived hepatic cells

Gene therapy-corrected autologous hepatocyte-like cells from induced pluripotent stem cells for the treatment of pediatric single enzyme disorders

  • Post author:
  • Post category:

Liver transplantation (LT) has been used to treat a variety of liver diseases. Within hours after birth, neonates can present with disorders of the urea cycle (UCDs), the critical metabolic…

Continue ReadingGene therapy-corrected autologous hepatocyte-like cells from induced pluripotent stem cells for the treatment of pediatric single enzyme disorders

Development of an hES Cell-Based Assay System for Hepatocyte Differentiation Studies and Predictive Toxicology Drug Screening

  • Post author:
  • Post category:

Drug-induced liver toxicity, including that from FDA-approved drugs, is the leading cause of liver failure in the US. One of the biggest road blocks to testing drug-induced liver toxicity prior…

Continue ReadingDevelopment of an hES Cell-Based Assay System for Hepatocyte Differentiation Studies and Predictive Toxicology Drug Screening

Molecular dissection of adult liver regeneration to guide the generation of hepatocytes from pluripotent stem cells

  • Post author:
  • Post category:

The liver is a promising target for cell therapy since it supports and functionally integrates transplanted cells. Human liver contains more than 50 billion cells and more than 10% replacement…

Continue ReadingMolecular dissection of adult liver regeneration to guide the generation of hepatocytes from pluripotent stem cells